Schlagwort: ‘Pricing’
NHSA: releasing the “Standards of the Contract Renewal of Reimbursed Drugs”
Recently, the National Healthcare Security Administration (NHSA) adjusted and released the “Standards of the Contract Renewal of Reimbursed Drugs,” which clarified the adjusted payment standards covering the entire life-cycle of drugs: A drug that has been on the reimbursement list for 8 years will stay on the list permanently; the price reduction of a reimbursed drug would be halved if this drug has been on the reimbursement list for more than 4 years and the price reduction is triggered by contract renewal or additional indications for this drug; innovative drugs, biological goods, and traditional Chinese medicines that have already been approved by the Measures for the Administration of Drug Registration can renew the contract through renegotiations with the state if the price reduction is triggered.
基本覆盖药品全生命周期 国家医保局发布谈判药品续约规则
来源：广东省人民政府 2023.07.24
国家医保局日前对《谈判药品规则续约》进行调整完善并发布，明确建立基本覆盖药品全生命周期的支付标准调整规则：对达到8年的谈判药纳入常规目录管理；对未达8年的谈判药，连续协议期达到或超过4年的品种以简易方式续约或新增适应症触发降价的，降幅减半；对于按照现行注册管理办法批准的1类化药、1类治疗用生物制剂，1类和3类中成药，在续约触发降价机制时，可以申请以重新谈判的方式续约。
Pricing pharmaceutical medical service in hospitals
Recently, the NMPA proposed that pharmaceutical medical services with clear patient needs, concrete service contents and target groups, and clear technical requirements should be priced to encourage pharmacy personnel to play an active role in promoting rational use of drugs and reducing drug waste; qualified provinces should be guided to carry out pilot projects of this new pricing policy for pharmaceutical medical services.
三部门发文，支持药师收取药学服务费
来源：医药网 2022.10.21
近日，国家医保局提出，对患者需求明确，服务内容和对象具体、技术路线清晰的药学服务事项，研究完善价格项目，激励药学人员在促进合理用药、减少资源浪费等方面发挥积极作用；指导有条件的省份率先开展药学服务类医疗服务价格项目政策试点。
Supervising drug price in designated retail pharmacies
On October 18th, Shanghai Sunshine Medical Procurement All-In-One Website released the “Notification on Drug Price Supervising Measures for Shanghai’s Pharmacy Chains.” The “Notification” requires designated pharmacy chains to upload drug pricing information to the ‘Shanghai Medical Procurement Service and Supervision Information System’ when selling drugs on the national reimbursement drug list; the uploaded drug prices are monitored by the “Red/Yellow Line” warning system, which creates an alert when the price exceeds the Yellow Line and rejects price adjustments when the price exceeds the Red Line.
定点药店药价监控来了
来源：医药网 2021.10.21
10月18日，上海阳光采购网发布《关于公布本市定点药店药品价格管理操作办法的通知》（以下简称“通知”）。通知显示，定点药店销售医保目录药品，须通过”上海市医疗采购服务与监管信息系统“上传价格信息；上传的药品价格由“红黄线”预警机制监测：价格高于黄线的，系统自动提醒；价格高于红线的，系统自动拦截。
The State Council: Normalize and Institutionalize the Centralized Procurement of Drugs
On 15th January, the State Council indicated that the implementation of Centrailised Procurement of Drugs (with target quantity) should be normalized and insitutionalized to lessen the burden on the masses; the drugs on the National Reimbursement Drug List that are in high demand and need large procurement amounts will be included in the fourth batch of the centralized procurement. At the same time, the Shanghai Sunshine Medical Procurement All-In-One company officially anounced the launch of the fourth batch of the National Centralized Procurement of Drugs.
国常会提出集采常态化制度化要求！第四批国采2月3日开标！
来源：医药网 2021.01.18
1月15日，国务院常务会议指出，应进一步常态化制度化实施推进药品集中带量采购改革，以减轻群众就医负担；基本医保药品目录内用量大、采购金额高的药品将被纳入第四批集中采购。与此同时，上海阳光医药采购网正式官宣启动开展第四批国家组织药品集中采购和使用工作。
Hainan: supervising the drug procurement process
On October 10th, the Hainan Medical Insurance Bureau issued the “Plan on Supervising and Evaluating the Medical Price in Hainan Province.” The “Plan” clarifies that drugs included in the procurement list on the website of the centralised procurement platform of Hainan Province should be supervised, which means that monitoring and early warning systems will be implemented as drugs are published on or removed from the website as well as during the processes of drug procurement, distribution, use, and purchase. In addition, a centralised drug procurement assessment for medical institutions should be developed, in which will be evaluated particularly whether medical institutions have obeyed the purchase agreement and paid for the drugs with in 30 days, the rate of drug cost compared with the whole medical costs in medical institutions, the rate and purchasement of unselected drugs, and illegal purchase behavior.
医保局推药品采购全流程监测预警！严抓30天回款率
来源：医药网 2020.10.12
10月10日，海南省医疗保障局印发《海南省医药价格综合监管评价服务工作方案》（以下称《工作方案》）。《工作方案》明确，将在海南省医药集中采购平台挂网采购的药品纳入监测内容，对药品的挂网、撤网、采购、配送、使用和回款等全流程实施监测预警。 另外，应设置医疗机构的药品集中采购考核，其中对于协议完成率、30天汇款率、药占比、非中选产品采购量及金额占比、违规采购行为等进行了重点评分规定。
Developing evaluating systems of drug pricing and bidding and procurement performence
On September 16th, the NHSA offically issued the “Guidelines on Establishing a Evaluating System of Drug Pricing and Bidding and Procurement Performence,” which stipulates that each province should establish and launch their own system before the end of 2020. The “Guidelines” clarifies that centralised procurement organizations of drugs and medical equipments should prevent pharmaceutical companies from fixing unreasonable drug price, such as via giving kickback to hospitals. At the meantime, the pharmaceutical companies that do not act properly will be documented and punished according to different levels of dishonesty while they are also encouraged to rectify to regain their credit score.
医保局：医药价格和招采信用评价年底前落地！
来源：医药网 2020.09.17
9月16日，国家医保局官网正式发布了《关于建立医药价格和招采信用评价制度的指导意见》（以下简称《意见》），要求各地于2020年底前建立并实施医药价格和招采信用评价制度。《意见》明确，药品和医用耗材集中采购机构应采取措施制止医药企业给予回扣等不合理定价行为。同时，应记录失信医药企业信息，根据不同失信等级采取不同处置措施，并鼓励企业整改，主动修复信用。
Pharmacy chains can only rise the price of drug in the reimbursement list by 15%
On September 1st, the “Reform Project on Improving the Functions of the Centralised Drug Procurement Platform and Promoting a Full Coverage of Payment Requirement of Drugs on the Reimbursement List in Zhejiang Province” was implemented. The “Project” indicates that drugs included in the list of online transactions on the provincal procurement platform of drugs and medical equipments are included in the provincal drug reimbursement list. Designated public medical institutions and private medical institutions should fix the drug price that accords with the price on the drug reimbursement list while pharmacy chains can rise the price upto 15% based on the price on the list.
9月1日起执行：医保用药 药店只能加价15%
来源：医药网 2020.09.03
9月1日，《浙江省提升药品集中采购平台功能推进医保药品支付标准全覆盖改革方案》正式实施。《方案》明确，所有纳入该省药械采购平台在线交易的医保目录内药品均纳入医保支付范围。其中，定点公立医疗机构与民营医疗机构医保药品执行相同的支付标准，定点零售药店医保支付标准统一按医疗机构支付标准上浮15%。
Wuhan: implementing the centralised procurement of the intensive monitoring drugs
On August 6th, the Joint Procurement Office of Drugs and Medical Equipments in Wuhan issued the first “Price List of Intensive Monitoring Drugs” and implemented the centralised procurement of 30 sorts of intensive monitoring drugs, which will last one year and is aimed to regulate a rational drug pricing and guiding medical institutions to regulate medication to reduce the financial burden on patients.
武汉市启动30种重点监控药品集中议价采购
来源：医药网 2020.08.06
8月6日，武汉市药械联合采购办公室公布武汉市首批《重点监控合理用药药品议价目录》，并正式启动武汉市30种重点监控药品集中议价采购，周期为一年，旨在促进药价合理形成，引导医疗机构规范用药，切实减轻患者药费负担。
Deepening the reform of the medical and health care system
On February 25th, the State Council issued the “Opinions on Deepening the Reform of the Medical and Health Care System.” The “Opinion” stipulates that medical institutions should improve the management of drug reimbursement lists, medical service protocols, and medicare settlement or increase the efficiency of medicare payment. Besides, the use of medical insurance funds should be strictly supervised, and insurance fraud will be dealt with according to legislation. In addition, the reform of centralized drug procurement should be deepened, and a pricing system that depends on the market should be established. Moreover, medical institutions should improve their service capacity and standardize new medical services, such as consulting over the internet.
关于深化医疗保障制度改革的意见
来源：医药网 2020.03.06
2月25日，国务院发布《关于深化医疗保障制度改革的意见》。《意见》要求，应完善医保目录、协议、结算管理，提升医保支付效率；完善医保基金监管，依法追究欺诈骗保行为；深化药品集中带量采购制度改革，并建立以市场为主导的药品价格形成机制；增强医疗服务能力，规范“互联网+医疗”等新服务模式发展。
Price management in medical institutions
On January 2nd, the National Health Commission issued the “Standard of Price Management in Medical Institutions,” which will come into effect as the date of promulgation. The “Standard” indicates that medical institutions should establish a price management system that is consisted of several departments. Besides, the “Standard” stipulates that medical institutions should make several staffs supervise the medical costs and adjust unreasonable charges. Besides, medical institutions should establish a system that can analyze and manage the medical service cost and make the costs of common medical services public.
国家卫健委：医疗机构内部价格行为管理规定
来源：医药网 2020.01.06
1月2日，国家卫健委发布《医疗机构内部价格行为管理规定》，并将自发布之日起施行。《规定》提出，各医疗机构应到建立由多部门组成的价格管理体系。《规定》要求，医疗机构应配备一定数量医疗服务价格工作人员，用于定期检查患者花费，纠正医院不规范收费；各医疗机构应建立医疗服务成本测算和成本控制管理制度，同时公示常用医疗服务项目的价格。